New Blood Test Could End Painful Endometriosis Surgery

Endometriosis, affecting about one in 10 UK women, typically involves an eight-year diagnostic delay. Currently, the sole reliable method for diagnosis and treatment is laparoscopy, an invasive surgical procedure. This approach is costly and carries risks, including a mortality rate of 1 in 12,000 and a 1 in 500 chance of serious complications.

Anna Sherrington, who endured debilitating pain and misdiagnoses for over a decade before her diagnosis at 32, described laparoscopies as "crazy" and "barbaric." She emphasized the critical need for increased research funding to accelerate progress in women's health and reduce lengthy waiting lists.

Researchers at Robert Gordon University in Aberdeen are pioneering a potential blood test. Their study analyzes molecular changes related to blood clotting, seeking a biomarker for quicker diagnosis. This innovation aims to reduce patient suffering and streamline access to treatment, addressing the current diagnostic challenges.

Dr. Gael Morrow and Dr. Lucy Whitaker both acknowledge the pressing need for improved diagnostic methods. While acknowledging the current reliance on laparoscopy, they highlight its invasive nature and recovery time. They also note that superficial peritoneal endometriosis, common in 80% of patients, is often not visible on ultrasound, underscoring the limitations of non-surgical imaging.